Emelie Öhnstedt
Project manager at UCR-Uppsala Clinical Research center
- E-mail:
- emelie.ohnstedt@ucr.uu.se
- Visiting address:
- Dag Hammarskjölds väg 38
- Postal address:
- Uppsala Science Park
Dag Hammarskjölds väg 38
751 85 UPPSALA
Download contact information for Emelie Öhnstedt at UCR-Uppsala Clinical Research center
Publications
Recent publications
Part of American Journal of Physiology - Gastrointestinal and Liver Physiology, 2024
- DOI for Oral administration of CXCL12-expressing Limosilactobacillus reuteri improves colitis by local immunomodulatory actions in preclinical models
- Download full text (pdf) of Oral administration of CXCL12-expressing Limosilactobacillus reuteri improves colitis by local immunomodulatory actions in preclinical models
Part of eClinicalMedicine, 2023
- DOI for Engineered bacteria to accelerate wound healing: an adaptive, randomised, double-blind, placebo-controlled, first-in-human phase 1 trial
- Download full text (pdf) of Engineered bacteria to accelerate wound healing: an adaptive, randomised, double-blind, placebo-controlled, first-in-human phase 1 trial
2023
Part of Pharmaceutics, 2022
- DOI for Accelerated Wound Healing in Minipigs by On-Site Production and Delivery of CXCL12 by Transformed Lactic Acid Bacteria
- Download full text (pdf) of Accelerated Wound Healing in Minipigs by On-Site Production and Delivery of CXCL12 by Transformed Lactic Acid Bacteria
Accelerated wound healing by on-site production and delivery of CXCL12
2021
All publications
Articles in journal
Part of American Journal of Physiology - Gastrointestinal and Liver Physiology, 2024
- DOI for Oral administration of CXCL12-expressing Limosilactobacillus reuteri improves colitis by local immunomodulatory actions in preclinical models
- Download full text (pdf) of Oral administration of CXCL12-expressing Limosilactobacillus reuteri improves colitis by local immunomodulatory actions in preclinical models
Part of eClinicalMedicine, 2023
- DOI for Engineered bacteria to accelerate wound healing: an adaptive, randomised, double-blind, placebo-controlled, first-in-human phase 1 trial
- Download full text (pdf) of Engineered bacteria to accelerate wound healing: an adaptive, randomised, double-blind, placebo-controlled, first-in-human phase 1 trial
Part of Pharmaceutics, 2022
- DOI for Accelerated Wound Healing in Minipigs by On-Site Production and Delivery of CXCL12 by Transformed Lactic Acid Bacteria
- Download full text (pdf) of Accelerated Wound Healing in Minipigs by On-Site Production and Delivery of CXCL12 by Transformed Lactic Acid Bacteria
Part of Proceedings of the National Academy of Sciences of the United States of America, p. 1895-1900, 2018
- DOI for Accelerated wound healing in mice by on-site production and delivery of CXCL12 by transformed lactic acid bacteria
- Download full text (pdf) of Accelerated wound healing in mice by on-site production and delivery of CXCL12 by transformed lactic acid bacteria